Drug Shortage Report for TARO-DEFERASIROX (TYPE J)
| Report ID | 268844 |
| Drug Identification Number | 02507323 |
| Brand name | TARO-DEFERASIROX (TYPE J) |
| Common or Proper name | Deferasirox |
| Company Name | TARO PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | DEFERASIROX |
| Strength(s) | 180MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 30's Bottle |
| ATC code | V03AC |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2025-10-01 |
| Estimated end date | 2025-12-12 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-12-05 |
| Company comments | Available inventory expires Mar 2026 |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 130 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2025-12-05 | French | Compare |
| v5 | 2025-12-05 | English | Compare |
| v4 | 2025-11-11 | French | Compare |
| v3 | 2025-11-11 | English | Compare |
| v2 | 2025-10-06 | French | Compare |
| v1 | 2025-10-06 | English | Compare |
Showing 1 to 6 of 6